Artificial neural networks in laboratory medicine and medical outcome prediction

被引:35
作者
Tafeit, E
Reibnegger, G
机构
[1] Karl Franzens Univ Graz, Inst Med Chem, A-8010 Graz, Austria
[2] Karl Franzens Univ Graz, Pregl Lab, A-8010 Graz, Austria
关键词
supervised learning; feed-forward neural networks; unsupervised learning; Kohonen's self-organizing map;
D O I
10.1515/CCLM.1999.128
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Since the early nineties the number of scientific papers reporting on artificial neural network (ANN) applications in medicine has been quickly increasing. In the present paper, we describe in some detail the architecture of network types used most frequently in ANN applications in the broad field of laboratory medicine and clinical chemistry, present a technique-structured review about the recent ANN applications in the field, and give information about the improvements of available ANN software packages. ANN applications are divided into two main classes: supervised and unsupervised methods. Most of the described supervised applications belong to the fields of medical diagnosis (n=7) and outcome prediction (n=9). Laboratory and clinical data are presented to multilayer feed-forward ANNs which are trained by the back propagation algorithm. Results are often better than those of traditional techniques such as linear discriminant analysis, classification and regression trees (CART), Cox regression analysis, logistic regression, clinical judgement or expert systems. Unsupervised ANN applications provide the ability of reducing the dimensionality of a dataset. Low-dimensional plots can be generated and visually understood and compared. Results are very similar to that of cluster analysis and factor analysis. The ability of Kohonen's self-organizing maps to generate 2D maps of molecule surface properties was successfully applied in drug design.
引用
收藏
页码:845 / 853
页数:9
相关论文
共 37 条
[1]   The use of self-organizing neural networks in drug design [J].
Anzali, S ;
Gasteiger, J ;
Holzgrabe, U ;
Polanski, J ;
Sadowski, J ;
Teckentrup, A ;
Wagener, M .
PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1998, 9-11 :273-299
[2]  
ASTION ML, 1993, CLIN CHEM, V39, P1998
[3]   APPLICATION OF NEURAL NETWORKS TO THE CLASSIFICATION OF GIANT-CELL ARTERITIS [J].
ASTION, ML ;
WENER, MH ;
THOMAS, RG ;
HUNDER, GG ;
BLOCH, DA .
ARTHRITIS AND RHEUMATISM, 1994, 37 (05) :760-770
[4]   Artificial neural network: Improving the quality of breast biopsy recommendations [J].
Baker, JA ;
Kornguth, PJ ;
Lo, JY ;
Floyd, CE .
RADIOLOGY, 1996, 198 (01) :131-135
[5]   APPLICATION OF ARTIFICIAL NEURAL NETWORKS TO CLINICAL MEDICINE [J].
BAXT, WG .
LANCET, 1995, 346 (8983) :1135-1138
[6]  
Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO
[7]  
2-Y
[8]  
Ellenius J, 1997, CLIN CHEM, V43, P1919
[9]  
FLOYD CE, 1994, CANCER, V74, P2944, DOI 10.1002/1097-0142(19941201)74:11<2944::AID-CNCR2820741109>3.0.CO
[10]  
2-F